CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported fourth-quarter profit of $1.47 billion.
The Cambridge, Massachusetts-based company said it had profit of $3.61 per share.
The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $4.66 per share.
The biotechnology company posted revenue of $5.08 billion in the period, which also fell short of Street forecasts. Eight analysts surveyed by Zacks expected $5.09 billion.
For the year, the company reported profit of $8.36 billion, or $20.12 per share. Revenue was reported as $19.26 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
